Evgen Pharma PLC on Tuesday said it found further evidence of SFX-01 activity in models of colon cancer.
The clinical stage drug development company developing sulforaphane-based medicines said the...
The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:
----------
RTW Biotech Opportunities Ltd - New York-based investment...
Evgen Pharma PLC - clinical stage drug development company developing sulforaphane-based medicines - Notes that its partner in autism spectrum disorder and other neurodevelopmental disorders Stalicla...
Evgen Pharma PLC - clinical stage drug development company developing sulforaphane-based medicines - Appoints Toni Hanninen as permanent chief financial officer, adding that he will now join the...
Evgen Pharma PLC - Cheshire, England-based clinical stage drug developer - Highlights article published in respected industry publication the Medicine Maker, by its Chief Business Officer, Helen...
The following stocks are the leading risers and fallers on AIM in London on Wednesday.
----------
AIM - WINNERS
----------
Blancco Technology Group PLC, up 23% at 219.56 pence, 12-month range...
The following stocks are the leading risers and fallers on AIM in London on Wednesday.
----------
AIM - WINNERS
----------
Pathfinder Minerals PLC, up 21% at 0.55 pence, 12-month range 0.35p - 0.95p.... | March 22, 2023
The following is a round-up of updates on exposure to Silicon Valley Bank by London-listed companies, issued on Monday and not separately reported by Alliance News:
----------
FTSE... | March 13, 2023
Octopus AIM VCT plc Portfolio Update The investment portfolio of Octopus AIM VCT plc as at 21 September 2022 is as follows : Investee CompanySectorBook cost Movement in valuation Fair Value... | September 21, 2022